Evidence map›Paper›PMID 35387375›Full record

ArticleThe Canadian journal of hospital pharmacy2022

Reasons for Low Regulatory Body Discipline Rates for Canadian Hospital Pharmacists.

Ariane Fung, Ai-Leng Foong-Reichert, Sherilyn K D Houle, Kelly A Grindrod

Abstract read
In one paragraph

Article in The Canadian journal of hospital pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Assessment of the feasibility of including community pharmacies under the regulation of the saudi food and drug authority.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2025
    Article
  2. The Hidden Epidemic.The Canadian journal of hospital pharmacy · 2022
    Article
  3. L'autre épidémie.The Canadian journal of hospital pharmacy · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ariane Fung, BSc, PharmD, was, at the time of the study, a pharmacy student at the University of Waterloo School of Pharmacy, Kitchener, Ontario. She will be starting a hospital pharmacy residency in mid-2022.
Ai-Leng Foong-Reichert, BSc, PharmD, is a candidate in the PhD program, University of Waterloo School of Pharmacy, Kitchener, Ontario.
Sherilyn K D Houle, BSP, PhD, is an Assistant Professor with the University of Waterloo School of Pharmacy, Kitchener, Ontario.
Kelly A Grindrod, BScPharm, ACPR, PharmD, MSc, is an Associate Professor with the University of Waterloo School of Pharmacy, Kitchener, Ontario.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Past research on disciplinary action by pharmacist regulatory bodies has shown that most cases concern community pharmacists, with few occurring in a hospital setting. Objective: To investigate how discipline-related issues involving pharmacists are dealt with by hospital pharmacy departments in Canada. Methods: Hospital pharmacy directors and managers from small, medium, and large hospitals across Canada were invited to participate in semi-structured telephone interviews. The interview questions focused on the discipline process in participants' organizations, the situations when reporting to the regulatory body is deemed to be warranted, possible penalties, and recommendations for improving the regulatory body or organizational discipline process. Results: Ten participants, from British Columbia, Saskatchewan, Ontario, New Brunswick, Prince Edward Island, and Newfoundland and Labrador, agreed to be interviewed. Five key themes emerged as contributing to lower rates of hospital pharmacist discipline cases being escalated to the regulatory college level: robust organizational discipline processes independent from the regulatory college, a practice environment promoting competence, union representation, preference for a remedial approach to discipline, and lack of clarity about when to report to the regulatory authority. Conclusions: This study identified a number of reasons why discipline of hospital pharmacists by a regulatory body may be less prevalent than discipline relating to community pharmacists. The main reasons may be lack of clarity about when to report a case to the regulator and a lack of transparency, given that many cases are handled internally within hospitals. Environmental supports for competence and employee protections (e.g., through a union) may also reduce discipline cases.

Indexed as

disciplinary actiondiscipline organisationnellehospital pharmacymesure disciplinaireorganizational disciplinepharmaciepharmacie hospitalièrepharmacy

Identifiers

PMID35387375
PMCPMC8956463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.